The SEC is currently investigating if the company violated securities law by allegedly fabricating payments for phantom nursing shifts at its London subsidiary. The company denies the allegation.
If the equity firm moves forward with possible plans for an initial public offering during the investigation, the company would be required to disclose that information, which may or may not deter investors from purchasing the stock.
According an analyst interviewed in the report, the investigation will be most likely to affect the timing of the IPO.
Read The Tennessean‘s report on the possible HCA IPO.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
